BiomX Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in its Charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
|
|
||
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area
code: +
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
On April 21, 2025, BiomX Inc. (the “Company”) held a special meeting of stockholders of the Company (the “Special Meeting”). A total of 16,824,049 shares of the Company’s Common Stock were present in person or represented by proxy at the Special Meeting. At the Special Meeting, stockholders voted in favor of the following items of business:
Proposal No. 1-Issuance Proposal
The Company’s stockholders voted to approve the exercise of certain warrants into shares of common stock of the Company, par value $0.0001 per share, in accordance with Section 713 of the NYSE American LLC Listed Company Guide, previously issued in private placements (i) pursuant to that certain Securities Purchase Agreement, dated February 25, 2025, by and among the Company and the investors signatory thereto and (ii) pursuant to that certain Inducement Letter, dated February 25, 2025, by and among the Company and the holders signatory thereto.
| Voted For | Voted Against | Abstain | Broker Non-Votes | |||||||||||
| 16,069,898 | 29,372 | 18,428 | 0 | |||||||||||
Proposal No. 2-Adjournment Proposal
The Company’s stockholders voted to approve the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for Proposal 1.
| Voted For | Voted Against | Abstain | Broker Non-Votes | |||||||||||
| 16,784,878 | 29,325 | 9,846 | 0 | |||||||||||
No adjournment of the Special Meeting was necessary. The results reported above are final voting results.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: April 23, 2025 | BiomX Inc. | ||
| By: | /s/ Jonathan Solomon | ||
| Name: | Jonathan Solomon | ||
| Title: | Chief Executive Officer | ||